Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (13,570)	$ (19,019)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	21,424	22,745
Amortization of deferred financing costs	669	673
Change in fair value of contingent consideration	(43)	1,953
Share-based compensation expense	3,585	1,845
Impairment of intangible assets		6,632
Accrued interest expense	(4,116)	553
Deferred taxes, net	(4,833)	(544)
Other	(10)	(22)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	3,615	1,187
Other receivables	5,307	(612)
Inventory	(1,939)	(758)
Other current assets	(1,699)	(1,143)
Operating lease right-of-use assets	1,807	1,592
Other assets	(436)	88
Related parties, net	(1,831)	246
Accounts payable	466	1,616
Accrued expenses	(3,948)	(5,895)
Settlement processing funds, net	(29,222)	(129,102)
Operating lease liabilities	(1,822)	(1,674)
Other	(65)	26
Net cash used in operating activities	(26,661)	(119,613)
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired		(3,030)
Purchase of equipment and improvements	(5,167)	(6,503)
Acquisition of intangible assets	(1,702)	(1,660)
Collections of notes receivable	12	1,400
Net cash used in investing activities	(6,857)	(9,793)
Cash flows from financing activities:
Proceeds from long-term debt	176,747	126,597
Repayments of long-term debt	(176,420)	(117,713)
Deferred financing costs paid		(2)
Contingent consideration paid	(781)	(331)
Repurchases of shares to satisfy minimum tax withholding	(339)	(130)
Proceeds from exercise of common stock options	17
Distribution to non-controlling interests holders	(63)	(5,480)
Net cash (used in) provided by financing activities	(839)	2,941
Effect of exchange rate changes on cash and cash equivalents	(12,635)	(3,149)
Net (decrease) increase in cash and cash equivalents	(46,992)	(129,614)
Cash and cash equivalents, beginning of period	304,089	350,697
Cash and cash equivalents, end of period	$ 257,097	$ 221,083